Search Results - "Gazzard, B G"

Refine Results
  1. 1

    Immune Reconstitution Inflammatory Syndrome Associated With Kaposi's Sarcoma by BOWER, M, NELSON, M, YOUNG, A. M, THIRLWELL, C, NEWSOM-DAVIS, T, MANDALIA, S, DHILLON, T, HOLMES, P, GAZZARD, B. G, STEBBING, J

    Published in Journal of clinical oncology (01-08-2005)
    “…A proportion of patients with HIV infection who subsequently receive highly active antiretroviral therapy (HAART) exhibit a deterioration in their clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment by Steel, A. W., Mela, C. M., Lindsay, J. O., Gazzard, B. G., Goodier, M. R.

    Published in Alimentary pharmacology & therapeutics (01-01-2011)
    “…Aliment Pharmacol Ther 2011; 33: 115–126 Summary Background  Distinct functional subsets of natural killer cells potentially contribute to the pathology of…”
    Get full text
    Journal Article
  4. 4

    A 48-Week, Randomized, Open-Label Comparison of Three Abacavir-Based Substitution Approaches in the Management of Dyslipidemia and Peripheral Lipoatrophy by Moyle, G J, Baldwin, C, Langroudi, B, Mandalia, S, Gazzard, B G

    “…BACKGROUND:The mechanisms by which dyslipidemia and lipoatrophy develop during antiretroviral therapy are not clear. No treatment of lipoatrophy is currently…”
    Get full text
    Journal Article
  5. 5

    The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic by Fox, P A, Seet, J E, Stebbing, J, Francis, N, Barton, S E, Strauss, S, Allen-Mersh, T G, Gazzard, B G, Bower, M

    Published in Sexually transmitted infections (01-04-2005)
    “…Background: Previous studies have reached differing conclusions about the utility of anal cytology as a screening tool for anal intraepithelial neoplasia…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Changing Pattern of AIDS-defining Illnesses with the Introduction of Highly Active Antiretroviral Therapy (HAART)in a London Clinic by Ives, N.J., Gazzard, B.G., Easterbrook, P.J.

    Published in The Journal of infection (01-02-2001)
    “…Objectives:To quantify the progressive impact of combination antiretroviral therapy (ART) on the incidence of AIDS-defining illnesses (ADIs) over a 9-year…”
    Get full text
    Journal Article
  8. 8

    Switching from twice‐daily abacavir and lamivudine to the once‐daily fixed‐dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy by Maitland, D, Jackson, A, Osorio, J, Mandalia, S, Gazzard, BG, Moyle, GJ

    Published in HIV medicine (01-09-2008)
    “…Background Patients prefer fewer pills and once‐daily (qd) dosing without food restrictions. We assessed the impact on adherence [by Medication Event…”
    Get full text
    Journal Article
  9. 9

    Paclitaxel for anthracycline-resistant AIDS-related Kaposi’s sarcoma: clinical and angiogenic correlations by Stebbing, J., Wildfire, A., Portsmouth, S., Powles, T., Thirlwell, C., Hewitt, P., Nelson, M., Patterson, S., Mandalia, S., Gotch, F., Gazzard, B. G., Bower, M.

    Published in Annals of oncology (01-11-2003)
    “…Background: Murine data indicate that angiogenesis is central to the aetiopathogenesis of Kaposi’s sarcoma (KS). Therefore, we measured angiogenic cytokines…”
    Get full text
    Journal Article
  10. 10

    Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned by Martin, TCS, Scourfield, A, Rockwood, N, Martin, NK, Patel, N, Nelson, M, Gazzard, BG

    Published in HIV medicine (01-03-2013)
    “…Objectives The aim of the study was to identify possible causes of pancreatic insufficiency in patients with HIV infection. Methods A retrospective analysis of…”
    Get full text
    Journal Article
  11. 11

    A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis by Jackson, A G A, Else, L J, Mesquita, P M M, Egan, D, Back, D J, Karolia, Z, Ringner-Nackter, L, Higgs, C J, Herold, B C, Gazzard, B G, Boffito, M

    Published in Clinical pharmacology and therapeutics (01-09-2014)
    “…Rilpivirine long‐acting (RPV‐LA) is a parenteral formulation enabling prolonged plasma exposure. We explored its multiple‐compartment pharmacokinetics (PK)…”
    Get full text
    Journal Article
  12. 12

    Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules by Portsmouth, SD, Osorio, J, McCormick, K, Gazzard, BG, Moyle, GJ

    Published in HIV medicine (01-05-2005)
    “…Background Adherence to antiretroviral therapy is critical to treatment outcomes. Adherence studies in other therapeutic areas of medicine suggest that…”
    Get full text
    Journal Article
  13. 13

    Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis by Cartledge, J D, Midgely, J, Gazzard, B G

    Published in Journal of clinical pathology (01-06-1997)
    “…AIMS: To compare the serum concentrations of itraconazole and hydroxyitraconazole after treatment with itraconazole cyclodextrin solution and itraconazole…”
    Get full text
    Journal Article
  14. 14

    Reasons for non-adherence to antiretroviral therapy: Patients' perspectives provide evidence of multiple causes by Walsh, J. C., Horne, R., Dalton, M., Burgess, A. P., Gazzard, B. G.

    Published in AIDS care (01-12-2001)
    “…The objective of the study was to define common reasons for non-adherence (NA) to highly active antiretroviral therapy (HAART) and the number of reasons…”
    Get full text
    Journal Article
  15. 15

    British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011 by Taylor, GP, Anderson, J, Clayden, P, Gazzard, BG, Fortin, J, Kennedy, J, Lazarus, L, Newell, M‐L, Osoro, B, Sellers, S, Tookey, PA, Tudor‐Williams, G, Williams, A

    Published in HIV medicine (01-08-2011)
    “…To prevent the transmission of HIV infection during the postpartum period, the British HIV Association and Children's HIV Association (BHIVA/CHIVA) continue to…”
    Get full text
    Journal Article
  16. 16

    Investigation of chronic diarrhoea in acquired immunodeficiency syndrome. A prospective study of 155 patients by Blanshard, C, Francis, N, Gazzard, B G

    Published in Gut (01-12-1996)
    “…BACKGROUND AND AIMS: The optimum diagnostic investigation for patients with acquired immunodeficiency syndrome (AIDS) and diarrhoea is not known. Often no…”
    Get full text
    Journal Article
  17. 17

    Immunological and virological consequences of patient‐directed antiretroviral therapy interruption during chronic HIV‐1 infection by Burton, C. T., Nelson, M. R., Hay, P., Gazzard, B. G., Gotch, F. M., Imami, N.

    Published in Clinical and experimental immunology (01-11-2005)
    “…Summary Increasing numbers of patients are choosing to interrupt highly active antiretroviral therapy (HAART). We describe the effect of patient‐directed…”
    Get full text
    Journal Article
  18. 18

    Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea by Keating, J, Bjarnason, I, Somasundaram, S, Macpherson, A, Francis, N, Price, A B, Sharpstone, D, Smithson, J, Menzies, I S, Gazzard, B G

    Published in Gut (01-11-1995)
    “…Intestinal function is poorly defined in patients with HIV infection. Absorptive capacity and intestinal permeability were assessed using 3-O-methyl-D-glucose,…”
    Get full text
    Journal Article
  19. 19

    Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone by Jones, R, Sawleshwarkar, S, Michailidis, C, Jackson, A, Mandalia, S, Stebbing, J, Bower, M, Nelson, M, Gazzard, BG, Moyle, GJ

    Published in HIV medicine (01-11-2005)
    “…Background The use of highly active antiretroviral therapy (HAART) has profoundly altered the life expectancy of individuals infected with HIV. Metabolic…”
    Get full text
    Journal Article
  20. 20